Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)
UGN-102 治疗复发性低级别中危非肌层浸润性膀胱癌的一线化疗:一项单臂、开放标签的 3 期试验 (ENVISION)
期刊:Journal of Urology
影响因子:6.8
doi:10.1097/JU.0000000000004296
Prasad, Sandip M; Shishkov, Dimitar; Mihaylov, Nikola Vladimirov; Khuskivadze, Alexandre; Genov, Pencho; Terzi, Vasyl; Kates, Max; Huang, William C; Louie, Michael J; Raju, Sunil; Burger, Brent; Meads, Andrew; Schoenberg, Mark